A high neutrophil-to-lymphocyte ratio is a poor prognostic factor for castration-resistant prostate cancer patients who undergo abiraterone acetate or enzalutamide treatment.
Takashi KawaharaMasashi KatoKenichi TabataIppei KojimaHiroshi YamadaOsamu KamihiraHideyasu TsumuraMasatsugu IwamuraHiroji UemuraYasuhide MiyoshiPublished in: BMC cancer (2020)
A higher NLR was associated with a poorer OS for CRPC patients who received ABI or ENZ. The NLR was positively correlated with prostate cancer progression.